Medicared For All Logo

David Kamelhar MD in New York, New York

Home New York New York

David Kamelhar MD has Pulmonary Disease as his primary medical specialty. Their primary office is: 38 E 32nd St in New York, New York.

They're a part of the: David L Kamelhar Md Pllc medical group which has around 2 members. You can call their office at 212-685-6611 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended New York University School Of Medicine and graduated in 1974 (around 51 years of experience). They are listed as doing telehealth appointments.


David L Kamelhar MD Office Phone and Directions

David Kamelhar MD
David L Kamelhar Md Pllc
38 E 32nd St
New York, New York 10016
212-685-6611


Patient Ratings
Please rate your experience with David Kamelhar MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 212-685-6611


Enter a starting address:


Healthcare Info for David Kamelhar MD

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: New York University School Of Medicine
Graduation Year: 1974
The Primary Medical Specialty for David Kamelhar MD is listed as: Pulmonary Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 51
PAC (PECOS ID)#: 3072570738
NPI #: 1891795787
NPI Created On: 07/21/2005
NPI Last Updated Listed as: 11/18/2008
Primary Taxonomy Code: 207RP1001X
License Number:
126062
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Measurement and graphic recording of total and timed exhaled air capacity
  3. Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
  4. Test for exercise-induced lung stress
  5. Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
  6. Determination of lung volumes using plethysmography
  7. Measurement of lung diffusing capacity
  8. New patient office or other outpatient visit, typically 45 minutes
  9. New patient office or other outpatient visit, typically 60 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 40 minutes
  13. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802333781

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 821670985

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: LONHALA MAGNAIR

Open Associated Drug #1: 63402-301-01


Payments Total: $36

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721623

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721625

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721627

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $104

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721631

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721633

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 851721635

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Respiratory

Name of Drug #1: Arikayce

Open Associated Drug #1: 71558-590-28


Pulmonary Disease Professionals in New York

1 St Ave And 16th St
New-york, NY
Icahn School Of Medicine At Mount Sinai

1 Gustave L Levy Pl
New-york, NY
Icahn School Of Medicine At Mount Sinai

1000 10th Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

1111 Amsterdam Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

440 W 114th St
New-york, NY
Icahn School Of Medicine At Mount Sinai

1111 Amsterdam Ave
New-york, NY
Icahn School Of Medicine At Mount Sinai

Providers in David L Kamelhar Md Pllc

1.David Kamelhar Md

38 E 32nd St
New York Ny 10016-5566
David L Kamelhar Md Pllc
Pulmonary Disease

2.Eric Teller Md

38 E 32nd St
New York Ny 10016-5566
David L Kamelhar Md Pllc
Pulmonary Disease

View all 2 members of David L Kamelhar Md Pllc medical group